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Background: The feasibility of total laparoscopic pancreaticoduodenectomy (TLPD) has been estab-
lished. Laparoscopic major venous resection during TLPD has not been reported. The aim of the present
study was to describe the technique and outcomes of patients undergoing TLPD with major venous
resection.
Methods: Retrospective review of all consecutive patients undergoing TLPD and major venous resection
from July 2007 to December 2010 was performed. Patient demographics and peri-operative outcomes
were retrieved. Data are presented as mean  standard deviation (SD) or median with range.
Results: Out of 129 patients undergoing TLPD, major venous resection was performed in 11 patients
with a mean age of 71 years. Median operative time and blood loss was 413 (301–666) min and 500
(75–2800) ml, respectively. Venous resection included tangential (n = 10) and segmental resection (n = 1).
Venous reconstruction included patch (n = 4), suture (n = 4), stapled (n = 2) and a left renal vein
interposition graft (n = 1). Median mesoportal clamp time was 35 (10–82) min. There was no 30-day or
in-hospital mortality. Post-operative imaging was available in 10 patients with 100% patency at the
venous reconstruction site.
Conclusions: Laparoscopic major venous resection during TLPD is feasible in selected patients. Exten-
sive experience with complex laparoscopic pancreatic resection and reconstruction is advocated before
attempting this procedure.
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Introduction
Enthusiasm for minimally invasive approaches in patients
requiring a pancreaticoduodenectomy has recently gained
momentum and has stemmed from excellent outcomes of lap-
aroscopic distal pancreatectomy.1,2 Several single-institutional
series have now reported the feasibility and safety of total lap-
aroscopic pancreaticoduodenectomy (TLPD) and suggest advan-
tages similar to those reported for minimally invasive
approaches in other procedures.3–5 TLPD has been performed
for malignant indications in 65% to 96% of reported patients
and although comparative trials are lacking, initial outcomes are
promising.
Advances in the surgical treatment of patients with pancreatic
malignancy have also become apparent in traditional open
approaches. Whereas patients with malignant involvement of the
portal vein (PV) or superior mesenteric vein (SMV) were previ-
ously considered unresectable and were either excluded from
operative treatment or underwent a pancreaticoduodenectomy
with a high rate of margin positivity, several series now demon-
strate the feasibility of concomitant major venous resection when
necessary to achieve a macroscopic and microscopic negative (R0)
resection. While randomized-controlled trials have not been
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performed, comparative studies have reported peri-operative and
oncological outcomes that are similar to patients undergoing a
pancreaticoduodenectomy without venous involvement.6–13
Currently, major venous involvement has been considered a
relative contraindication for the laparoscopic approach to a pan-
creaticoduodenectomy given the limited experience with TLPD
and the added complexity of vascular resection and reconstruc-
tion. We report the first series of TLPD with major venous resec-
tion for patients with suspected malignant involvement of the PV
or SMV.
Methods
After institutional review board approval, a retrospective review of
our prospectively maintained database was performed of all con-
secutive patients undergoing TLPD from July 2007 to December
2010, at Mayo Clinic in Rochester, MN, USA. Patients having
undergone concomitant major venous resection and reconstruc-
tion were included in the present study. Indications for venous
resection included expected malignant adherence or invasion of
the PV or SMV. Consideration for the laparoscopic approach in
patients requiring major venous resection and reconstruction
occurred only after substantial experience with TLPD without
venous resection (>60 cases) and significant experience in open
pancreaticoduodenectomy with and without major venous resec-
tion and reconstruction.
Procedure
The technique of TLPD has been described previously.3 Typically,
assessment of the plane posterior to the pancreatic neck is per-
formed early in the procedure to either confirm the extent of
malignant mesoportal venous involvement demonstrated on pre-
operative imaging or to identify unsuspected involvement. In the
event that the tumour originates within or extends into the unci-
nate process, a posterior, superior mesenteric artery (SMA)
approach is performed early to assess resectability and to facilitate
the uncinate dissection when venous involvement is present.
Combined with an anterior approach to the SMA and uncinate
dissection, this facilitates isolation of the involved portion of vein
to allow en-bloc resection. Exposure of the PV, SMV and distal
splenic vein is accomplished for complete major venous control in
anticipation of venous resection. To minimize mesoportal clamp
time, the remainder of the pancreaticoduodenectomy dissection is
completed reserving the venous transection as the final step in the
resection.
Systemic intravenous unfractionated heparin (3000 to 5000
units) is given before clamping of the mesoportal system. Venous
clamping is performed with atraumatic endo vessel clamps (Aes-
culap Inc., Center Valley, PA, USA) using a dedicated applier that
facilitates control and precise placement. When feasible, a curved
clamp is used for tangential occlusion, avoiding complete disrup-
tion of the mesoportal blood flow. For longer venous resection
(>3 cm), circumferential involvement >25%, or segmental resec-
tions, individual clamping of the portal, superior mesenteric and
splenic vein is performed. Venous resection is then performed
sharply with scissors, leaving the involved vein en-bloc with the
pancreaticoduodenectomy specimen.
The technique of venous resection and reconstruction is based
on the extent and location of venous involvement. Where less than
50% of the circumference is involved, tangential resection with
primary suture closure (<25% involvement) or patch venorrha-
phy (25–50% involvement) is generally preferred. For patch
reconstruction, we favour the use of a bovine pericardial graft
(Synovis Life Technologies Inc, St. Paul, MN, USA) over an
autologous vein. Segmental resection is performed when expected
circumferential venous involvement is greater than 50%. A
primary end-to-end reconstruction is performed when possible;
otherwise an autologous left renal vein interposition graft is used.
All methods of venous reconstruction utilize a 5–0 Prolene suture.
Post-operatively, low-dose (81 mg) aspirin is prescribed and is
continued for 3 months. In patients with malignancy and a history
of thrombosis, full anticoagulation with warfarin is generally
instituted. Post-operative imaging was obtained to assess patency
of venous reconstruction and to rule out thrombosis.
Data are presented as mean  standard deviation (SD) or
median with range.
Results
Out of the 129 patients undergoing TLPD, laparoscopic major
venous resection was performed in 11 patients with a mean age of
71 years. Patient demographics and peri-operative characteristics
are listed in Table 1. The median body mass index (BMI) (kg/m2)
and American Society of Anesthesiologists (ASA) score were 24
(17–35) and 2 (2–4), respectively. Four patients had previous
abdominal operations that included partial colectomy, ventral/
umbilical hernia repair and appendectomy. Indication for
a pancreaticoduodenectomy included pancreatic ductal adenocar-
cinoma (n = 9), neuroendocrine carcinoma (n = 1) and indeter-
minate pancreatic head mass (n = 1). One patient underwent
conversion to open for anticipated difficult venous and pancreatic
reconstruction early in the experience; the remaining patients
underwent total laparoscopic resection and reconstruction. In two
patients, robotic assistance was used for pancreaticobiliary recon-
struction after pure laparoscopic resection and venous recon-
struction.
Vascular resection was performed based on concerns of malig-
nant adherence or invasion in all patients. Venous resection
included the SMV (n = 6), PV (n = 3), or both (n = 2) and
consisted of a tangential (n = 10) or segmental (n = 1) resection.
Venous reconstruction included primary suture venorrhaphy in
four patients, patch venorrhaphy in four (Fig. 1), tangential sta-
pling in two and interposition graft using the left renal vein in one
patient (Figs 2,3). The overall median mesoportal clamp time was
35 (10 to 82) min. In three patients, complete mesoportal occlu-
sion was unnecessary (stapled technique in two and primary
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suture venorrhaphy in one). Median operative time and blood loss
were 413 (301–666) min and 500 (75–2800) ml, respectively.
Histopathology confirmed pancreatic ductal adenocarcinoma
in nine patients, neuroendocrine carcinoma in one and mass-
forming autoimmune pancreatitis in one. A complete macro-
scopic and microscopic margin negative resection (R0) was
obtained in 9 out of 10 patients (90%) with malignant disease. In
three patients, re-excision into the pancreatic body was necessary
to achieve an R0 resection after initial pancreatic neck margins
were microscopically positive on frozen section analysis. One
patient underwent laparoscopic completion pancreatectomy
because of poor quality of the pancreatic remnant. In the patient
with neuroendocrine carcinoma, tumour thrombus was noted in
an inferior pancreaticoduodenal venous tributary of the SMV
with venous invasion confirmed on histopathology. One patient
in this series had an R1 resection as a result of microscopic pres-
ence of ductal adenocarcinoma at the retroperitoneal (SMA)
margin. Mass-forming autoimmune pancreatitis was demon-
strated on the final histology of one patient who had initially
presented with obstructive jaundice and was found to have a 2-cm
pancreatic head mass with biliary and pancreatic ductal dilatation.
Pre-operative endoscopic ultrasound-guided fine needle aspira-
tion was performed and demonstrated atypical cells on cytology.
Operative findings were that of considerable perivascular fibrosis
and a dense, focal adherence to the lateral wall of the PV that
prompted tangential venous resection.
The median number of lymph nodes harvested for this cohort
was 19 (9–45) with 50% of patients with a malignant histology
demonstrating regional lymph node metastases.
Post-operative complications occurred in six patients and
included a pancreatic anastomotic leak in three, post-operative
anaemia/haemorrhage requiring a transfusion in three, arrhyth-
mia in two, transient renal failure in one and delayed gastric
emptying in one. Median length of hospital stay was 7 days (4–35).
Table 1 Characteristics of 11 patients undergoing TLPD with major venous resection
Patient Age (years) BMI (kg/m2) Resection/reconstruction Operative time (min) EBL (ml) T size (cm) R0/R1 LOS (days)
1 50 24 T / Patch 301 900 4.5 R0 6
2 58 17 T / Stapled 371 450 3.7 R0 5
3 68 23 T / Suture 422 600 4.4 R0 4
4 58 28 T / Stapled 388 450 5 R0 24
5 77 29 T / Suture 480 100 4.3 R1 7
6 79 24 T / Suture 380 300 2 R0 8
7 78 22 T / Patch 653 800 3.8 R0 35
8 80 35 T / Suture 413 500 2 R0 35
9 70 27 T / Patch 453 75 2.9 R0 14
10 81 24 T / Patch 370 500 4 R0 7
11 80 22 S / RVIG 666 2800 5.1 R0 7
Median 71* 24 – 413 500 4 – 7
*Mean.
T, tangential resection; S, segmental resection; RVIG, renal vein interposition graft; BMI, body mass index; EBL, estimated blood loss; LOS,
length of stay.
Figure 1 Intra-operative photo of patch venorrhaphy after tangential
venous resection
Figure 2 Intra-operative photo of distal venous anastomosis using
an autologous left renal vein interposition graft after segmental
venous resection
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There was no 30-day or in-hospital mortality. The median
follow-up for this cohort was 7.2 (1.5–19) months. Computed
tomography imaging was available in 10 patients greater than 1
month post-operatively which demonstrated patency of the
mesoportal venous system without evidence of thrombosis in all
patients. The single patient with no imaging at follow-up was alive
and well 6 months post-operatively, but had refused adjuvant
treatment or imaging after R0 resection of stage IB, pancreatic
adenocarcinoma.
Discussion
Total laparoscopic pancreaticoduodenectomy has been estab-
lished as feasible and safe in several centres with two series report-
ing experience in more than 60 patients.3,4 While adequate
comparative trials are still lacking, peri-operative outcomes of
TLPD are favourable and appear comparable to those reported for
open approaches.3,4,14 Given the relatively short follow-up and
small numbers of patients, adequate disease-free and overall sur-
vival outcomes are not established for TLPD in patients with
pancreatic malignancy. Surrogates of the adequacy of oncological
resection such as the number of lymph nodes harvested, margin
status and short-term outcomes appear comparable, albeit, poten-
tial selection and reporting bias preclude a valid interpretation of
these initial results.
Advances in the surgical treatment of pancreatic malignancy
have also included a more aggressive operative approach for
patients with malignant major venous involvement. Previously
considered unresectable, many centres now perform en-bloc
major venous resection with pancreaticoduodenectomy in these
patients. The rationale for this approach has been to increase the
number of candidates for resection and to improve the margin
negative resection rate for those with venous involvement. While
randomized-controlled trials have not been performed, several
retrospective comparative trials have reported similar outcomes
for patients requiring venous resection as a result of malignant
involvement compared with those that do not.6,9 Performed pre-
dominantly in high-volume centres specializing in pancreatic
disease, this approach has been limited to open approaches owing
to the limited experience of TLPD and the added complexity of
major venous resection and reconstruction.
The present study is the first to describe the technique and
outcomes of a series of patients undergoing laparoscopic major
venous resection and reconstruction. Caution should be apparent
in review of the course of events that led to the application of
laparoscopic approaches to major venous resection at our institu-
tion. In our early experience with TLPD, possible malignant
involvement of the PV or SMV was considered a contraindication
for the laparoscopic approach and these patients underwent open
pancreaticoduodenectomy with major venous resection.3
However, after considerable experience with TLPD, it became
evident that laparoscopic venous resection and reconstruction
could also be performed. With the advantages afforded by laparos-
copy including excellent exposure, magnification and positive
intra-abdominal pressure (limiting low pressure venous bleed-
ing), we felt that a laparoscopic approach to major venous resec-
tion may be safe and even beneficial. Before attempting the first
laparoscopic major venous resection, extensive experience and
planning were ensured. First, sufficient experience with an open
pancreaticoduodenectomy, with and without major venous resec-
tion, in over 100 patients was obtained. Second, TLPD was per-
formed in over 60 patients without venous resection. Finally,
techniques of laparoscopic major vascular resection and recon-
struction were investigated in a swine model. In the author’s
opinion, this preparation cannot be overemphasized as fatigue
(long-operative times) and frustration (procedure complexity)
with TLPD alone in the early experience is the inappropriate time
for application of the added complexity and risk of major vascular
resection and reconstruction.
Peri-operative outcomes in this series appear similar to those
reported in recent series using the open approaches6–9 (Table 2). In
spite of the potential limitations of a small series and potential
selection bias, these data suggest that laparoscopic major venous
resection with pancreaticoduodenectomy is feasible and safe in
selected patients.
Various techniques of venous resection (tangential vs. segmen-
tal) and reconstruction (suture vs. patch or end-to-end vs. inter-
position graft) and have been reported without clear advantages
of one particular technique over another.6–8 In the present series,
all but one patient (91%) underwent tangential resection and
reconstruction as opposed to a more predominant use of segmen-
tal resection reported by others.6–12 Whether this difference is as a
result of patient selection bias or to the author’s criteria for select-
ing the reconstruction method is unclear. We did not change our
approach to vascular resection based on the laparoscopic
approach. For open cases, the author uses the same criteria of
extent of circumferential involvement to determine whether tan-
gential or segmental resection is performed. Our preferred tech-
nique for reconstruction after segmental resection is a primary
Figure 3 Intra-operative photo of completed venous reconstruction
using autologous left renal vein interposition
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end-to-end anastomosis after sufficient mobilization, reserving
interposition grafting for those circumstances where end-to-end
is not feasible. The patient undergoing segmental resection in the
present series had a 4-cm segment of PV/SMV resected and there-
fore underwent a left renal vein interposition graft for reconstruc-
tion as previously described.15
The median total venous clamp time (35 min) in this early
series may be longer than is typically reported in open procedures
and may represent the learning curve of laparoscopic venous
resection. In spite of this, we observed no complications that could
be directly attributed to a prolonged clamp time, and overall
complication rates are similar to those reported for open
approaches.16
This series cannot establish definitive outcomes of laparoscopic
major venous resection with pancreaticoduodenectomy, but does
suggest the feasibility and safety in selected patients. The unique
exposure, magnification and positive pressure afforded by the lap-
aroscopic approach may demonstrate advantages of this approach
in larger series and comparative trials. The authors recommend
the acquisition of considerable experience in both open PD with
and without vascular resection, and TLPD without vascular resec-
tion before attempting laparoscopic major venous resection and
reconstruction.
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